Magenta Therapeutics Inc (MGTA)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-09-29 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
24 670
+1.3%
13,63336 252 USD |
24 670 +1.3% | 13,63 | 336 252 USD | |
| 2023-09-28 | 2023-09-26 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
30 000
+1.6%
13,15394 500 USD |
30 000 +1.6% | 13,15 | 394 500 USD | |
| 2023-09-25 | 2023-09-22 | A Achat |
Chief Medical Officer Dirigeant |
2 000
+100.0%
13,2026 400 USD |
2 000 +100.0% | 13,20 | 26 400 USD | |
| 2023-09-25 | 2023-09-21 | A Achat |
Chief Medical Officer Dirigeant |
2 000
+inf%
13,2026 400 USD |
2 000 +inf% | 13,20 | 26 400 USD | |
| 2023-09-21 | 2023-09-19 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
30 000
+1.6%
13,20396 000 USD |
30 000 +1.6% | 13,20 | 396 000 USD | |
| 2023-09-13 | 2023-09-13 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
9 367
+0.5%
11,76110 156 USD |
9 367 +0.5% | 11,76 | 110 156 USD | |
| 2023-09-13 | 2023-09-12 | A Achat |
Fairmount Funds Management LLC Administrateur non-exécutif Actionnaire important |
14 887
+0.8%
10,85161 524 USD |
14 887 +0.8% | 10,85 | 161 524 USD | |
| 2023-02-09 | 2023-02-08 | V Vente | Actionnaire important |
1 500 000
-32.9%
0,821 230 000 USD |
1 500 000 -32.9% | 0,82 | 1 230 000 USD | |
| 2023-02-09 | 2023-02-07 | V Vente | Actionnaire important |
2 200 000
-32.6%
0,831 826 000 USD |
2 200 000 -32.6% | 0,83 | 1 826 000 USD | |
| 2020-07-01 | 2020-06-29 | A Achat | Administrateur non-exécutif |
1 250 000
+inf%
8,0010 000 000 USD |
1 250 000 +inf% | 8,00 | 10 000 000 USD | |
| 2020-01-10 | 2020-01-10 | VP Vente planifiée |
See Remarks |
11 200
-4.3%
15,25170 800 USD |
11 200 -4.3% | 15,25 | 170 800 USD | |
| 2020-01-03 | 2020-01-02 | VP Vente planifiée |
See Remarks |
2 800
-1.1%
15,1042 280 USD |
2 800 -1.1% | 15,10 | 42 280 USD | |
| 2020-01-03 | 2020-01-02 | VP Vente planifiée |
Chief Medical Officer |
11 294
-57.6%
15,04169 817 USD |
11 294 -57.6% | 15,04 | 169 817 USD | |
| 2019-12-26 | 2019-12-24 | VP Vente planifiée |
ISACSON CHRISTINA K. Chief Business Officer |
4 463
-5.1%
16,0171 453 USD |
4 463 -5.1% | 16,01 | 71 453 USD | |
| 2019-12-26 | 2019-12-24 | VP Vente planifiée |
ZDRAVESKI ZORAN See Remarks |
7 902
-5.8%
16,00126 432 USD |
7 902 -5.8% | 16,00 | 126 432 USD | |
| 2019-12-26 | 2019-12-23 | VP Vente planifiée |
ZDRAVESKI ZORAN See Remarks |
4 181
-3.0%
16,0367 021 USD |
4 181 -3.0% | 16,03 | 67 021 USD | |
| 2019-12-26 | 2019-12-23 | VP Vente planifiée |
ISACSON CHRISTINA K. Chief Business Officer |
9 867
-10.1%
16,03158 168 USD |
9 867 -10.1% | 16,03 | 158 168 USD | |
| 2019-12-23 | 2019-12-23 | VP Vente planifiée |
See Remarks |
2 897
-1.1%
15,1043 755 USD |
2 897 -1.1% | 15,10 | 43 755 USD | |
| 2019-12-20 | 2019-12-20 | VP Vente planifiée |
See Remarks |
76 711
-22.2%
15,161 162 617 USD |
76 711 -22.2% | 15,16 | 1 162 617 USD | |
| 2019-12-20 | 2019-12-20 | VP Vente planifiée |
DAVIS JOHN C. JR Chief Medical Officer |
919
-10.0%
15,0013 785 USD |
919 -10.0% | 15,00 | 13 785 USD | |
| 2019-12-13 | 2019-12-10 | VP Vente planifiée |
See Remarks |
4 392
-1.3%
15,1066 319 USD |
4 392 -1.3% | 15,10 | 66 319 USD | |
| 2019-12-11 | 2019-12-10 | VP Vente planifiée |
DAVIS JOHN C. JR Chief Medical Officer |
17 055
-67.3%
15,00255 825 USD |
17 055 -67.3% | 15,00 | 255 825 USD | |
| 2019-12-11 | 2019-12-09 | VP Vente planifiée |
DAVIS JOHN C. JR Chief Medical Officer |
4 614
-35.7%
15,0069 210 USD |
4 614 -35.7% | 15,00 | 69 210 USD | |
| 2019-12-02 | 2019-12-02 | V Vente |
Chief Scientific Officer |
2 500
-1.0%
13,2133 036 USD |
2 500 -1.0% | 13,21 | 33 036 USD | |
| 2019-12-02 | 2019-12-02 | V Vente |
Chief Scientific Officer |
1 373
-0.6%
13,3118 279 USD |
1 373 -0.6% | 13,31 | 18 279 USD | |
| 2019-12-02 | 2019-12-02 | V Vente |
Chief Scientific Officer |
3 627
-1.5%
12,7446 205 USD |
3 627 -1.5% | 12,74 | 46 205 USD | |
| 2019-11-25 | 2019-11-20 | V Vente |
Chief Scientific Officer |
5 000
-2.0%
12,0060 000 USD |
5 000 -2.0% | 12,00 | 60 000 USD | |
| 2019-11-01 | 2019-11-01 | V Vente |
Chief Scientific Officer |
5 000
-1.9%
10,6753 334 USD |
5 000 -1.9% | 10,67 | 53 334 USD | |
| 2019-10-03 | 2019-10-01 | V Vente |
Chief Scientific Officer |
5 000
-1.9%
10,0150 064 USD |
5 000 -1.9% | 10,01 | 50 064 USD | |
| 2019-09-19 | 2019-09-19 | VP Vente planifiée |
Chief Scientific Officer |
1 656
-0.6%
12,0019 872 USD |
1 656 -0.6% | 12,00 | 19 872 USD | |
| 2019-09-16 | 2019-09-12 | VP Vente planifiée |
Chief Scientific Officer |
844
-0.3%
12,0010 128 USD |
844 -0.3% | 12,00 | 10 128 USD | |
| 2019-09-04 | 2019-09-03 | VP Vente planifiée |
Chief Scientific Officer |
5 000
-1.8%
10,1150 531 USD |
5 000 -1.8% | 10,11 | 50 531 USD | |
| 2019-08-01 | 2019-08-01 | VP Vente planifiée |
Chief Scientific Officer |
2 500
-0.9%
13,4133 523 USD |
2 500 -0.9% | 13,41 | 33 523 USD | |
| 2019-08-01 | 2019-08-01 | VP Vente planifiée |
Chief Scientific Officer |
5 000
-1.8%
13,4267 109 USD |
5 000 -1.8% | 13,42 | 67 109 USD | |
| 2019-07-02 | 2019-07-01 | VP Vente planifiée |
Chief Scientific Officer |
2 500
-0.9%
14,4236 051 USD |
2 500 -0.9% | 14,42 | 36 051 USD | |
| 2019-07-02 | 2019-07-01 | VP Vente planifiée |
Chief Scientific Officer |
5 000
-1.8%
14,3971 933 USD |
5 000 -1.8% | 14,39 | 71 933 USD | |
| 2019-06-24 | 2019-06-21 | VP Vente planifiée |
Chief Business Officer |
5 415
-5.2%
16,0787 019 USD |
5 415 -5.2% | 16,07 | 87 019 USD | |
| 2019-06-24 | 2019-06-21 | VP Vente planifiée |
See Remarks |
12 331
-3.4%
15,11186 321 USD |
12 331 -3.4% | 15,11 | 186 321 USD | |
| 2019-06-24 | 2019-06-20 | VP Vente planifiée |
See Remarks |
1 669
-0.5%
15,1025 202 USD |
1 669 -0.5% | 15,10 | 25 202 USD | |
| 2019-06-18 | 2019-06-17 | VP Vente planifiée |
Chief Scientific Officer |
7 500
-2.6%
13,90104 267 USD |
7 500 -2.6% | 13,90 | 104 267 USD | |
| 2019-03-22 | 2019-03-20 | V Vente |
14 245
-100.0%
17,86254 416 USD |
14 245 -100.0% | 17,86 | 254 416 USD | ||
| 2019-03-22 | 2019-03-20 | V Vente | Actionnaire important |
14 245
-100.0%
17,86254 416 USD |
14 245 -100.0% | 17,86 | 254 416 USD | |
| 2018-06-27 | 2018-06-25 | A Achat |
See Remarks Administrateur exécutif |
400
+0.1%
15,006 000 USD |
400 +0.1% | 15,00 | 6 000 USD | |
| 2018-06-27 | 2018-06-25 | A Achat | Administrateur non-exécutif |
6 600
+3.0%
15,0099 000 USD |
6 600 +3.0% | 15,00 | 99 000 USD |